The present invention is directed to cells comprising a recombinant polynucleotide sequence that encodes a telomerase reverse transcriptase protein, variant, or fragment having telomerase catalytic activity when complexed with a telomerase RNA.
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
US Patent 07195911 Mammalian cells that have increased proliferative capacityUS Patent 7195911 Mammalian cells that have increased proliferative capacity